Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amir Englund

Showing results (1-10 of 32) with videos related to

Pageof 4
Sort By:
Schizophrenia Bulletin|January 19, 2018
Commentary on "The Potential of Cannabidiol Treatment for Cannabis Users With Recent-Onset Psychosis"Philip McGuire, Amir Englund, Sagnik Bhattacharyya
Addiction (Abingdon, England)|January 17, 2022
Could COVID expand the future of addiction research? Long-term implications in the pandemic eraAmir Englund, Stephen Sharman, Basak Tas, et al.
Current Pharmaceutical Design|June 22, 2012
Cannabis in the arm: what can we learn from intravenous cannabinoid studies?Amir Englund, James M Stone, Paul D Morrison
Pharmacogenomics|May 7, 2014
Towards a personalized treatment in depression: endocannabinoids, inflammation and stress responseZuzanna E Zajkowska, Amir Englund, Patricia A Zunszain
Journal of Psychopharmacology (Oxford, England)|July 11, 2020
Does cannabis complement or substitute alcohol consumption? A systematic review of human and animal studiesConstanza Risso, Sadie Boniface, Meenakshi Sabina Subbaraman, et al.
Addiction (Abingdon, England)|February 6, 2020
How experimental cannabinoid studies will inform the standardized THC unitLucy Chester, Edward Chesney, Dominic Oliver, et al.
The Lancet. Psychiatry|March 6, 2017
Can we make cannabis safer?Amir Englund, Tom P Freeman, Robin M Murray, et al.
Neuroscience and Biobehavioral Reviews|December 23, 2022
Effects of cannabinoids on resting state functional brain connectivity: A systematic reviewValentina Lorenzetti, Alexandra Gaillard, Diny Thomson, et al.
Therapeutic Advances in Psychopharmacology|September 25, 2020
Lack of evidence for the effectiveness or safety of over-the-counter cannabidiol productsEdward Chesney, Philip McGuire, Tom P Freeman, et al.
Journal of Psychopharmacology (Oxford, England)|April 11, 2023
Co-use of cannabis and alcohol before and after Canada legalized nonmedical cannabis: A repeat cross-sectional studyErin Hobin, Ashini Weerasinghe, Sadie Boniface, et al.
Pageof 4

Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
Schizophrenia Bulletin|January 19, 2018
Commentary on "The Potential of Cannabidiol Treatment for Cannabis Users With Recent-Onset Psychosis"Philip McGuire, Amir Englund, Sagnik Bhattacharyya
Addiction (Abingdon, England)|January 17, 2022
Could COVID expand the future of addiction research? Long-term implications in the pandemic eraAmir Englund, Stephen Sharman, Basak Tas, et al.
Current Pharmaceutical Design|June 22, 2012
Cannabis in the arm: what can we learn from intravenous cannabinoid studies?Amir Englund, James M Stone, Paul D Morrison
Pharmacogenomics|May 7, 2014
Towards a personalized treatment in depression: endocannabinoids, inflammation and stress responseZuzanna E Zajkowska, Amir Englund, Patricia A Zunszain
Journal of Psychopharmacology (Oxford, England)|July 11, 2020
Does cannabis complement or substitute alcohol consumption? A systematic review of human and animal studiesConstanza Risso, Sadie Boniface, Meenakshi Sabina Subbaraman, et al.
Addiction (Abingdon, England)|February 6, 2020
How experimental cannabinoid studies will inform the standardized THC unitLucy Chester, Edward Chesney, Dominic Oliver, et al.
The Lancet. Psychiatry|March 6, 2017
Can we make cannabis safer?Amir Englund, Tom P Freeman, Robin M Murray, et al.
Neuroscience and Biobehavioral Reviews|December 23, 2022
Effects of cannabinoids on resting state functional brain connectivity: A systematic reviewValentina Lorenzetti, Alexandra Gaillard, Diny Thomson, et al.
Therapeutic Advances in Psychopharmacology|September 25, 2020
Lack of evidence for the effectiveness or safety of over-the-counter cannabidiol productsEdward Chesney, Philip McGuire, Tom P Freeman, et al.
Journal of Psychopharmacology (Oxford, England)|April 11, 2023
Co-use of cannabis and alcohol before and after Canada legalized nonmedical cannabis: A repeat cross-sectional studyErin Hobin, Ashini Weerasinghe, Sadie Boniface, et al.
Pageof 4